Yu Xiu, F. Meng, J. Ou, Zhuo Wang, Jing Du, K. Zhao, Yunlong Wang, Zhishen Chen, Q. Tian, Baosheng Sun
{"title":"宫颈癌根治放疗211例预后分析","authors":"Yu Xiu, F. Meng, J. Ou, Zhuo Wang, Jing Du, K. Zhao, Yunlong Wang, Zhishen Chen, Q. Tian, Baosheng Sun","doi":"10.3760/CMA.J.ISSN.0254-5098.2019.10.009","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the curative effect and prognostic factors of radical radiotherapy for cervical cancer. \n \n \nMethods \nA total of 211 patients with stage ⅠA-ⅢB cervical cancer who underwent therapy in department of radiotherapy, Tumor Hospital of Jilin province between June 2014 and February 2017, were analyzed retrospectively. All patients received radical radiotherapy with or without concurrent chemotherapy. Short-term and long-term efficacy and related prognostic factors were observed. Kaplan-Meier method was used for survival analysis, Log-rank test was used for univariate analysis, and Cox proportional hazards regression model was used for multivariate analysis. \n \n \nResults \nThe 2-year overall survival (OS) and disease free survival (DFS) were 83.4% and 72.5%, respectively. During the follow-up periods, 46 patients (21.8%) died, including two from non-tumor-related diseases, and one from second primary colon cancer. Totally 57 patients (27%) had recurrence and metastasis, including 16 (28.1%) with local recurrence, 27 (47.4%) with distant metastasis, and 14 with local recurrence and distant metastasis(24.6%). Univariate analysis showed that 2-year OS and DFS were significantly correlated with pathological type, pre-treatment squamous cell carcinoma antigen (SCC) value and FIGO stage (OS: χ2=7.123, 6.014, 8.398, P<0.05; DFS: χ2=11.832, 8.003, 7.731, P<0.05). In addition to the above factors, 2-year DFS was also associated with pelvic lymph node metastasis (χ2=9.286, P<0.05). Multivariate analysis showed that pathological type, pre-treatment SCC value and FIGO stage were independent prognostic factors of OS(HR=2.963, 2.473, 2.574, P<0.05). The independent prognosis factors affecting DFS included pathological type, pre-treatment SCC value and pelvic lymph node metastasis (HR =3.014, 1.988, 1.914, P<0.05). \n \n \nConclusions \nBy means of radical radiotherapy, cervical cancer patients with adenocarcinoma, pre-treatment SCC levels ≥30 ng/ml and advanced stage have poor prognosis, so more active treatment strategy should be adopted. \n \n \nKey words: \nCervical cancer; Radical radiotherapy; Efficacy; Prognosis","PeriodicalId":36403,"journal":{"name":"中华放射医学与防护杂志","volume":"17 1","pages":"762-767"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic analysis of radical radiotherapy for 211 cases of cervical cancer\",\"authors\":\"Yu Xiu, F. Meng, J. Ou, Zhuo Wang, Jing Du, K. Zhao, Yunlong Wang, Zhishen Chen, Q. Tian, Baosheng Sun\",\"doi\":\"10.3760/CMA.J.ISSN.0254-5098.2019.10.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the curative effect and prognostic factors of radical radiotherapy for cervical cancer. \\n \\n \\nMethods \\nA total of 211 patients with stage ⅠA-ⅢB cervical cancer who underwent therapy in department of radiotherapy, Tumor Hospital of Jilin province between June 2014 and February 2017, were analyzed retrospectively. All patients received radical radiotherapy with or without concurrent chemotherapy. Short-term and long-term efficacy and related prognostic factors were observed. Kaplan-Meier method was used for survival analysis, Log-rank test was used for univariate analysis, and Cox proportional hazards regression model was used for multivariate analysis. \\n \\n \\nResults \\nThe 2-year overall survival (OS) and disease free survival (DFS) were 83.4% and 72.5%, respectively. During the follow-up periods, 46 patients (21.8%) died, including two from non-tumor-related diseases, and one from second primary colon cancer. Totally 57 patients (27%) had recurrence and metastasis, including 16 (28.1%) with local recurrence, 27 (47.4%) with distant metastasis, and 14 with local recurrence and distant metastasis(24.6%). Univariate analysis showed that 2-year OS and DFS were significantly correlated with pathological type, pre-treatment squamous cell carcinoma antigen (SCC) value and FIGO stage (OS: χ2=7.123, 6.014, 8.398, P<0.05; DFS: χ2=11.832, 8.003, 7.731, P<0.05). In addition to the above factors, 2-year DFS was also associated with pelvic lymph node metastasis (χ2=9.286, P<0.05). Multivariate analysis showed that pathological type, pre-treatment SCC value and FIGO stage were independent prognostic factors of OS(HR=2.963, 2.473, 2.574, P<0.05). The independent prognosis factors affecting DFS included pathological type, pre-treatment SCC value and pelvic lymph node metastasis (HR =3.014, 1.988, 1.914, P<0.05). \\n \\n \\nConclusions \\nBy means of radical radiotherapy, cervical cancer patients with adenocarcinoma, pre-treatment SCC levels ≥30 ng/ml and advanced stage have poor prognosis, so more active treatment strategy should be adopted. \\n \\n \\nKey words: \\nCervical cancer; Radical radiotherapy; Efficacy; Prognosis\",\"PeriodicalId\":36403,\"journal\":{\"name\":\"中华放射医学与防护杂志\",\"volume\":\"17 1\",\"pages\":\"762-767\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华放射医学与防护杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.0254-5098.2019.10.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华放射医学与防护杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0254-5098.2019.10.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的探讨宫颈癌根治放疗的疗效及影响预后的因素。方法回顾性分析2014年6月至2017年2月在吉林省肿瘤医院放疗科治疗的211例ⅠA ~ⅢB期宫颈癌患者的临床资料。所有患者均接受根治性放疗,伴或不伴化疗。观察两组近期、远期疗效及相关预后因素。生存分析采用Kaplan-Meier法,单因素分析采用Log-rank检验,多因素分析采用Cox比例风险回归模型。结果2年总生存率(OS)为83.4%,无病生存率(DFS)为72.5%。在随访期间,46例患者(21.8%)死亡,其中2例死于非肿瘤相关疾病,1例死于第二原发性结肠癌。复发转移57例(27%),其中局部复发16例(28.1%),远处转移27例(47.4%),局部复发并远处转移14例(24.6%)。单因素分析显示,2年OS、DFS与病理类型、治疗前鳞状细胞癌抗原(SCC)值、FIGO分期有显著相关性(χ2=7.123、6.014、8.398,P<0.05;Dfs: χ2=11.832, 8.003, 7.731, p <0.05)。除上述因素外,2年DFS还与盆腔淋巴结转移相关(χ2=9.286, P<0.05)。多因素分析显示,病理类型、治疗前SCC值、FIGO分期是影响OS预后的独立因素(HR=2.963、2.473、2.574,P<0.05)。影响DFS的独立预后因素包括病理类型、治疗前SCC值、盆腔淋巴结转移(HR =3.014、1.988、1.914,P<0.05)。结论宫颈癌合并腺癌、治疗前SCC水平≥30 ng/ml及晚期患者经根治性放疗预后较差,应采取更积极的治疗策略。关键词:宫颈癌;激进的放射治疗;功效;预后
Prognostic analysis of radical radiotherapy for 211 cases of cervical cancer
Objective
To investigate the curative effect and prognostic factors of radical radiotherapy for cervical cancer.
Methods
A total of 211 patients with stage ⅠA-ⅢB cervical cancer who underwent therapy in department of radiotherapy, Tumor Hospital of Jilin province between June 2014 and February 2017, were analyzed retrospectively. All patients received radical radiotherapy with or without concurrent chemotherapy. Short-term and long-term efficacy and related prognostic factors were observed. Kaplan-Meier method was used for survival analysis, Log-rank test was used for univariate analysis, and Cox proportional hazards regression model was used for multivariate analysis.
Results
The 2-year overall survival (OS) and disease free survival (DFS) were 83.4% and 72.5%, respectively. During the follow-up periods, 46 patients (21.8%) died, including two from non-tumor-related diseases, and one from second primary colon cancer. Totally 57 patients (27%) had recurrence and metastasis, including 16 (28.1%) with local recurrence, 27 (47.4%) with distant metastasis, and 14 with local recurrence and distant metastasis(24.6%). Univariate analysis showed that 2-year OS and DFS were significantly correlated with pathological type, pre-treatment squamous cell carcinoma antigen (SCC) value and FIGO stage (OS: χ2=7.123, 6.014, 8.398, P<0.05; DFS: χ2=11.832, 8.003, 7.731, P<0.05). In addition to the above factors, 2-year DFS was also associated with pelvic lymph node metastasis (χ2=9.286, P<0.05). Multivariate analysis showed that pathological type, pre-treatment SCC value and FIGO stage were independent prognostic factors of OS(HR=2.963, 2.473, 2.574, P<0.05). The independent prognosis factors affecting DFS included pathological type, pre-treatment SCC value and pelvic lymph node metastasis (HR =3.014, 1.988, 1.914, P<0.05).
Conclusions
By means of radical radiotherapy, cervical cancer patients with adenocarcinoma, pre-treatment SCC levels ≥30 ng/ml and advanced stage have poor prognosis, so more active treatment strategy should be adopted.
Key words:
Cervical cancer; Radical radiotherapy; Efficacy; Prognosis